Athenex Inc (ATNX) is a biopharmaceutical company that focuses on developing and commercializing innovative therapies for cancer and other diseases. The company's product candidates include oral chemotherapy agents and immunotherapy products for cancer treatment, as well as therapies for other medical conditions. Athenex has a number of ongoing clinical trials for its product candidates, and is also engaged in collaborative partnerships with other pharmaceutical companies and research institutions to develop new therapies. The company is headquartered in Buffalo, New York and was founded in 2003.
Athenex Inc (ATNX) is a biopharmaceutical company that focuses on developing and commercializing innovative therapies for cancer and other diseases. The company's product candidates include oral chemotherapy agents and immunotherapy products for cancer treatment, as well as therapies for other medical conditions. Athenex has a number of ongoing clinical trials for its product candidates, and is also engaged in collaborative partnerships with other pharmaceutical companies and research institutions to develop new therapies. The company is headquartered in Buffalo, New York and was founded in 2003.